Tarsus Pharmaceuticals, Inc.
TARS
$44.20
-$0.56-1.25%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 40.00% | -8.07% | -2.05% | 8.39% | 31.25% |
Total Receivables | 33.49% | 58.59% | -1.74% | -1.66% | 77.04% |
Inventory | 3.24% | -7.94% | 29.66% | -45.61% | 29.90% |
Prepaid Expenses | -59.05% | 108.84% | 17.46% | -12.22% | -13.54% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 34.78% | -0.12% | -1.51% | 6.42% | 33.03% |
|
|||||
Total Current Assets | 34.78% | -0.12% | -1.51% | 6.42% | 33.03% |
Net Property, Plant & Equipment | 10.96% | -31.68% | -0.36% | 21.33% | 3.64% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -2.88% | -2.81% | 133.62% | -2.65% | -2.59% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -6.28% | 78.14% | 1.24% | 156.57% | 2.17% |
Total Assets | 32.83% | 0.18% | -0.14% | 7.89% | 31.56% |
|
|||||
Total Accounts Payable | 2.32% | 3.45% | 0.61% | 39.24% | 7.71% |
Total Accrued Expenses | -27.66% | 21.74% | 84.73% | 32.61% | -53.82% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -36.84% | -3.65% | 4.30% | 3.42% | 46.98% |
Total Finance Division Other Current Liabilities | 31.91% | 45.92% | 43.65% | -3.55% | 236.59% |
Total Other Current Liabilities | 31.91% | 45.92% | 43.65% | -3.55% | 236.59% |
Total Current Liabilities | 7.07% | 22.38% | 27.72% | 21.26% | 15.14% |
|
|||||
Total Current Liabilities | 7.07% | 22.38% | 27.72% | 21.26% | 15.14% |
Long-Term Debt | 0.19% | 0.19% | 0.18% | 139.13% | 0.38% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -14.42% | -9.78% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.83% | 9.83% | 11.41% | 68.22% | 8.12% |
|
|||||
Common Stock & APIC | 24.49% | 1.80% | 1.44% | 1.88% | 25.82% |
Retained Earnings | -6.97% | -6.86% | -7.47% | -11.87% | -14.60% |
Treasury Stock & Other | -52.51% | -48.27% | 296.59% | -179.37% | -3,050.00% |
Total Common Equity | 52.52% | -5.45% | -5.85% | -8.34% | 39.71% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 52.52% | -5.45% | -5.85% | -8.34% | 39.71% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 52.52% | -5.45% | -5.85% | -8.34% | 39.71% |
|